Ep 50 - Shalin Shah (CEO of Marius Pharmaceuticals) on the oral TRT partnership with Hims
Update: 2025-11-10
Description
Shalin Shah is the founder & CEO of Marius Pharmaceuticals, the company that partnered with $HIMS to launch oral testosterone (KYZATREX). We discuss how the partnership came about, the benefits of teaming up with $HIMS, and the future of TRT.
(00:41 ) Origin of the partnership
(02:55 ) Benefits of partnering with $HIMS
(04:14 ) Deal shape and exclusivity
(06:51 ) How KYZATREX will sit alongside compounded meds on the $HIMS platform
(09:22 ) Will KYZATREX be personalized?
(16:07 ) TRT as a schedule 3 substance
(21:39 ) Gearing up for 2026 launch of KYZATREX
(22:40 ) Future of TRT market
(27:29 ) Peptides
(29:44 ) Testosterone for females
Get full access to Hims House at himshouse.substack.com/subscribe
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
